Validation of an ELISA synthetic cannabinoids urine assay

Therapeutic Drug Monitoring

Volumn 37, Issue 5, 2015, Pages 661-669

  Barnes, Allan J ^a   Spinelli, Eliani ^a,b   Young, Sheena ^a   Martin, Thomas M ^c   Kleete, Kevin L ^c   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Office of the Secretary of Defense   (United States)

Author keywords

ELISA; Immunoassay; Synthetic cannabinoids

Indexed keywords

1 (5 FLUOROPENTYL) 3 (1 NAPHTHOYL)INDOLE; 1 BUTYL 3 (1 NAPHTHOYL)INDOLE; 3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID DERIVATIVE; DEXANABINOL; NON PRESCRIPTION DRUG; CANNABINOID; DIAGNOSTIC KIT;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; METABOLITE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION STUDY; DIAGNOSTIC KIT; IMMUNOLOGY; PROCEDURES; URINE;

CANNABINOIDS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; REAGENT KITS, DIAGNOSTIC;

EID: 84941887037     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0000000000000201     Document Type: Article

References (30)

1. Dresen S, Kneisel S, Weinmann W, et al. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples. J Mass Spectrom. 2011;46:163-171.
2. Pertwee RG. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem. 2010;17:1360-1381.
3. Porter AC, Felder CC. The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther. 2001;90:45-60.
4. Brents LK, Reichard EE, Zimmerman SM, et al. Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity. PLoS One. 2011;6:e21917.
5. Devane WA, Breuer A, Sheskin T, et al. A novel probe for the cannabinoid receptor. J Med Chem. 1992;35:2065-2069.
6. Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2011: National Estimates of Drug-related Emergency Department Visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
7. Harris CR, Brown A. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med. 2013;44:360-366.
8. Castellanos D, Singh S, Thornton G, et al. Synthetic cannabinoid use: a case series of adolescents. J Adolesc Health. 2011;49:347-349.
9. Every-Palmer S. Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend. 2011;117:152-157.
10. Simmons J, Cookman L, Kang C, et al. Three cases of "spice" exposure. Clin Toxicol (Phila). 2011;49:431-433.
11. Simmons JR, Skinner CG, Williams J, et al. Intoxication from smoking "spice". Ann Emerg Med. 2011;57:187-188.
12. U. S. Government. Synthetic drug abuse prevention act. 2012;1152b: S. 31871-S.32139.
13. European Monitoring Centre for Drugs, Drug Addiction (EMCDDA). Understanding the 'Spice' Phenomenon. Lisbon: EMCDDA; 2009. Available at: http://www.emcdda.europa.eu/html.cfm/index90917EN.html Accessed March 11, 2015.
14. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future National Results on Drug Use: 2012 Overview Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2012.
15. Hu X, Primack BA, Barnett TE, et al. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy. 2011;6:16.
16. Wohlfarth A, Scheidweiler KB, Chen X, et al. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LCMS/MS and library search. Anal Chem. 2013;85:3730-3738.
17. Grigoryev A, Melnik A, Savchuk S, et al. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:2519-2526.
18. Grigoryev A, Savchuk S, Melnik A, et al. Chromatography-mass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:1126-1136.
19. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci Int. 2010;200:141-147.
20. Hutter M, Broecker S, Kneisel S, et al. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J Mass Spectrom. 2012;47:54-65.
21. Scheidweiler KB, Jarvis MJ, Huestis MA. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Anal Bioanal Chem. 2015;407:883-897.
22. Moran CL, Le VH, Chimalakonda KC, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem. 2011;83:4228-4236.
23. de Jager AD, Warner JV, Henman M, et al. LC-MS/MS method for the quantitation of metabolites of eight commonly-used synthetic cannabinoids in human urine-an Australian perspective. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;897:22-31.
24. Yanes EG, Lovett DP. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;909:42-50.
25. Chimalakonda KC, Moran CL, Kennedy PD, et al. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal Chem. 2011;83:6381-6388.
26. Scheidweiler KB, Huestis MA. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2014;1327:105-117.
27. Griffiths P, Sedefov R, Gallegos A, et al. How globalization and market innovation challenge how we think about and respond to drug use: 'Spice' a case study. Addiction. 2010;105:951-953.
28. Barnes AJ, Young S, Spinelli E, et al. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci Int. 2014;241:27-34.
29. Spinelli E, Barnes AJ, Young S, et al. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Drug Test Anal. 28 Aug. 2014 [Epub ahead of print].
30. Arntson A, Ofsa B, Lancaster D, et al. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J Anal Toxicol. 2013;37:284-290.